91 related articles for article (PubMed ID: 16109557)
1. [Expressions of tumor necrosis factor receptor I and II in human gastric carcinoma].
Gao L; Bai L; Nan QZ; Cai LS; Cui JC; Dai JL; Lin Y; Shen Q
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):991-3, 997. PubMed ID: 16109557
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of IGF-1R and VEGF in gastric carcinoma].
Liu WD; Yu R; Zhou GR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jun; 25(6):529-30. PubMed ID: 19500509
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of TGIF, MMP9 and VEGF proteins and their clinicopathological relationship in gastric cancer].
Hu ZL; Wen JF; Shen M; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):70-4. PubMed ID: 16562680
[TBL] [Abstract][Full Text] [Related]
4. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of cyclinB1, FHIT and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic significance].
Li YZ; Zhao P
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(33):2337-41. PubMed ID: 20095356
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of hypoxia inducible factor-1alpha and insulin-like growth factor-II in gastric carcinoma: correlation with angiogenesis and prognosis].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):905-8. PubMed ID: 17953839
[TBL] [Abstract][Full Text] [Related]
7. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].
He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof].
Zhang FH; Zhou YN; Li GZ; Li Q; Lu B; Zhang ZY; Wu ZQ; Fan P; Hao TJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3279-82. PubMed ID: 19159555
[TBL] [Abstract][Full Text] [Related]
9. [Expression of tumor necrosis factor receptor on peripheral blood mononuclear cells from patients with primary hepatocellular carcinoma and effects of treatment on the expression].
Bai L; Huang CW; Gao L; Jiang B; Nan QZ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1099-100. PubMed ID: 12480583
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.
Wu C; Zhu Y; Jiang J; Zhao J; Zhang XG; Xu N
Acta Histochem; 2006; 108(1):19-24. PubMed ID: 16530813
[TBL] [Abstract][Full Text] [Related]
11. Expressions and clinical significances of angiopoietin-1, -2 and Tie2 in human gastric cancer.
Wang J; Wu K; Zhang D; Tang H; Xie H; Hong L; Pan Y; Lan M; Hu S; Ning X; Fan D
Biochem Biophys Res Commun; 2005 Nov; 337(1):386-93. PubMed ID: 16185665
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas.
Sakai K; Mori S; Kawamoto T; Taniguchi S; Kobori O; Morioka Y; Kuroki T; Kano K
J Natl Cancer Inst; 1986 Nov; 77(5):1047-52. PubMed ID: 3464796
[TBL] [Abstract][Full Text] [Related]
14. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma.
Emoto K; Sawada H; Yamada Y; Fujimoto H; Takahama Y; Ueno M; Takayama T; Uchida H; Kamada K; Naito A; Hirao S; Nakajima Y
Anticancer Res; 2001; 21(2B):1339-45. PubMed ID: 11396210
[TBL] [Abstract][Full Text] [Related]
15. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
He Q; Chen J; Lin HL; Hu PJ; Chen MH
Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
[TBL] [Abstract][Full Text] [Related]
16. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
17. [Study on tumor necrosis factor receptor of human gastric cancer cells].
Ran R; Wu Y; Fu H
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):28-31. PubMed ID: 10743050
[TBL] [Abstract][Full Text] [Related]
18. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
20. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
Li GH; Qian W; Song GQ; Hou XH
J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
